- Home
- CLDX vs OMCL Comparison
CLDX vs OMCL Comparison
Compare CLDX & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | OMCL |
|---|---|---|
| Founded | N/A | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 1.9B |
| IPO Year | 1995 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CLDX | OMCL |
|---|---|---|
| Price | $29.27 | $40.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | $46.60 | ★ $55.83 |
| AVG Volume (30 Days) | ★ 692.1K | 440.5K |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.25 |
| Revenue | $12,743,000.00 | ★ $787,309,000.00 |
| Revenue This Year | $111.39 | $6.77 |
| Revenue Next Year | $235.85 | $5.22 |
| P/E Ratio | ★ N/A | $163.40 |
| Revenue Growth | ★ 87.78 | 9.93 |
| 52 Week Low | $19.52 | $26.85 |
| 52 Week High | $35.83 | $51.84 |
Technical Indicators
Market Signals| Indicator | CLDX | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 40.54 | 42.83 |
| Support Level | $28.55 | $32.20 |
| Resistance Level | $30.90 | $45.06 |
| Average True Range (ATR) | 1.04 | 1.63 |
| MACD | -0.20 | -0.49 |
| Stochastic Oscillator | 22.48 | 8.14 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.